A study of two large European patient cohorts has found that for every 10% increase in butyrate-producing bacteria in a patient’s gut, the risk of hospitalization for any infection falls by between 14 and 25% across two large national cohorts.
Pharmalittle: Is Pascal Soriot leaving AstraZeneca? PBMs try to counter congressional crackdown
Hello, everyone, and nice to see you again after our extended break. A little time away is always a good thing, but now we have